ShRNA en tratamiento in vivo: perspectiva terapéutica en la enfermedad de Alzheimer

ShRNA en tratamiento in vivo: perspectiva terapéutica en la enfermedad de Alzheimer

Las enfermedades neurodegenerativas son un problema creciente en la población senil, con más de 20 millones de personas afectadas por la enfermedad de Alzheimer (EA) esporádica en el mundo y más de 5.000 portadores de EA familiar sólo en el departamento de Antioquia.

Bibliographic Details
Main Authors:	Kenneth Kosik, Álvaro Barrera Ocampo, Gloria Patricia Cardona Gómez
Format:	Article
Language:	Spanish
Published:	Universidad de Antioquia 2005-03-01
Series:	Iatreia
Subjects:	Alzheimer, BACE 1 RNA interferente
Online Access:	http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/1120

Similar Items

Interferentes eritrocitários e ambientais na anemia falciforme
by: Naoum Paulo C.
Published: (2000-01-01)

ARN de interferencia (ARNi): una herramienta eficaz en agrobiotecnología
by: Maira Gamero, et al.
Published: (2022-12-01)

Lobotomía de genes: terapia génica, RNA interferente y enfermedad de Alzheimer
by: Ryan Boudreau, et al.
Published: (2005-03-01)

Investigation of estrogenic activity in groundwater of Sao Paulo State
by: Gilson Alves Quináglia, et al.
Published: (2017-01-01)

La ATPasa6 participa en la maduración de ovocitos de cerdo in vitro
by: Fabiola Chong, et al.
Published: (2018-07-01)

Cicatriz tóxica de cesariana em cadela tratada com Terapia Neural
by: Bruna Aparecida Lima Gonçalves, et al.
Published: (2021-06-01)

The influence of Tween 80 on laccase production by Pleurotus sajor-caju and the efficiency of crude enzyme broth in the removal of bisphenol-A
by: Thaís Silva Teodoro, et al.
Published: (2018-11-01)

Role of BACE1 in Alzheimer’s synaptic function
by: Brati Das, et al.
Published: (2017-08-01)

BACE1 RNAi restores the composition of phosphatidylethanolamine-derivates related to memory improvement in aged 3xTg-AD mice
by: Javier Gustavo Villamil, et al.
Published: (2016-11-01)

Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
by: Alireza Vakilian, et al.
Published: (2019-06-01)

Hydroxytyrosol–Donepezil Hybrids Play a Protective Role in an In Vitro Induced Alzheimer’s Disease Model and in Neuronal Differentiated Human SH-SY5Y Neuroblastoma Cells
by: Jessica Maiuolo, et al.
Published: (2023-08-01)

Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer’s
by: Natalia Lopez-Barbosa, et al.
Published: (2020-01-01)

Synaptic abnormalities in a Drosophila model of Alzheimer’s disease
by: Siddhita D. Mhatre, et al.
Published: (2014-03-01)

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer
by: Arezou Sayad, et al.
Published: (2022-03-01)

The emerging role of β-secretases in cancer
by: Francesco Farris, et al.
Published: (2021-04-01)

The Potential Neuroprotective Effects of Extracts from Oat Seedlings against Alzheimer’s Disease
by: Won Seok Lee, et al.
Published: (2022-10-01)

Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
by: Žaklina Strezoska, et al.
Published: (2012-01-01)

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
by: Marika Marino, et al.
Published: (2022-04-01)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)

Drug-eluting beads bronchial arterial chemoembolization vs. conventional bronchial arterial chemoembolization in the treatment of advanced non-small cell lung cancer
by: Guocan Yu, et al.
Published: (2023-08-01)

Development and Structural Modification of BACE1 Inhibitors
by: Ting Gu, et al.
Published: (2016-12-01)

Insights from Drosophila melanogaster model of Alzheimer's disease
by: Nguyen Trong Tue, et al.
Published: (2020-01-01)

Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
by: Mohammad H. Baig, et al.
Published: (2018-02-01)

Silenciamento mediado por RNA interferente do gene <i>be1</i> que codifica para a Enzima de Ramificação do Amido I (SBE I) em Milho (<i>Zea</i> <i>mays</i> L.)
by: Thaís de Moura Cipriano, et al.
Published: (2007-06-01)

A Diet Containing Rutin Ameliorates Brain Intracellular Redox Homeostasis in a Mouse Model of Alzheimer’s Disease
by: Paloma Bermejo-Bescós, et al.
Published: (2023-03-01)

A Tale of Two Drug Targets: The Evolutionary History of BACE1 and BACE2
by: Christopher eSouthan, et al.
Published: (2013-12-01)

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease
by: Chami Linda, et al.
Published: (2012-10-01)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
by: Nuomin Li, et al.
Published: (2022-12-01)

Electrochemical Detection of Alzheimer’s Disease Biomarker, β-Secretase Enzyme (BACE1), With One-Step Synthesized Reduced Graphene Oxide
by: Jhilik Dey, et al.
Published: (2022-03-01)

Comparative Evaluation of the Antioxidant and Anti-Alzheimer’s Disease Potential of Coumestrol and Puerarol Isolated from Pueraria lobata Using Molecular Modeling Studies
by: Prashamsa Koirala, et al.
Published: (2018-03-01)

Reduction BACE1 expression via suppressing NF-κB mediated signaling by Tamibarotene in a mouse model of Alzheimer’s disease
by: Aimin Qiao, et al.
Published: (2021-06-01)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
by: Gerald Koelsch
Published: (2017-10-01)

MicroRNAs in Alzheimer's disease
by: Charlotte Delay, et al.
Published: (2012-05-01)

PTPRD and DCC Are Novel BACE1 Substrates Differentially Expressed in Alzheimer’s Disease: A Data Mining and Bioinformatics Study
by: Hannah A. Taylor, et al.
Published: (2022-04-01)

Delivery of Quantum Dot-siRNA Nanoplexes in SK-N-SH Cells for BACE1 Gene Silencing and Intracellular Imaging
by: Shengliang Li, et al.
Published: (2012-01-01)

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
by: Michael F. Egan, et al.
Published: (2019-08-01)

Engineering Periodic shRNA for Enhanced Silencing Efficacy
by: Wu, Connie, et al.
Published: (2021)

Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?
by: Meghna Dabur, et al.
Published: (2020-04-01)

Therapeutic Effects of Transplanted Exosomes Containing miR-29b to a Rat Model of Alzheimer’s Disease
by: Yavar Jahangard, et al.
Published: (2020-06-01)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-11-01)